Search

Electrocardiograms (ECGs) are a good baseline test for assessing cardiac rhythm. ECGs have not been reported in any zebra species and in very few Perissodactyla species. Standard limb, six-lead ECGs were recorded in 23 anesthetized Grevy's zebras (Equus grevyi). Heart rate, RR interval, P-wave duration, RR maximum/minimum, PR interval, QRS duration, QT interval, ST segment deviation, P-wave amplitude, QRS amplitude, and T-wave amplitude were measured and calculated from lead II ECGs from these Grevy's zebras. Several variables were tested, including gender, age (0-24, 24-48, 48-180, and >180 mo), weight (<350 kg or >350 kg), pregnancy status, and anesthetic differences (standard dose or supplemented dose), to see if they affected ECG values in these animals. There were no significant differences in any of the ECG parameters between genders. RR and QT intervals were longer in older zebras; heart rates were faster in younger zebras. The RR and PR intervals, as well as the QRS duration, were greater in heavier zebras; heart rates were faster in lighter zebras. The RR interval was significantly longer in pregnant zebras. There were no significant differences in any of the ECG parameters for zebras anesthetized with a standardized dose of the drug combination etorphine-detomidine-acepromazine compared to those receiving additional supplements of these drugs and/or ketamine. All other parameters were not significantly different among groups, except where noted previously. The results of this research indicate that differences in ECG parameters in zebras may occur between animals of different ages, weights, and pregnancy status and that these factors should be considered when interpreting the respective ECGs of these zebras.

A dose range was determined for anaesthesia of 20 recently boma-captured roan antelope (Hippotragus equinus) with the synthetic opiate A3080 combined with medetomidine and ketamine. A dose of 10-30 micro/kg A3080 (x = 20+/-8 microg/kg) combined with 5-21 microg/kg medetomidine (x = 13+/-7 microg/kg) plus 0.29-1.11 mg/kg ketamine (x = 0.71+/-0.24 mg/kg) was found to be safe and effective for the field conditions in this study. The anaesthesia produced by this drug combination was predictable and characterised by a short induction time, good muscle relaxation, and acceptable physiological parameters for anaesthesia periods ranging from 49-103 min (x = 64+/-19 min). The wide range (3-4-fold) of doses with acceptable results is also an indication that this drug combination has a wide margin of safety in roan antelope, making it desirable for field use. When 2 dose levels (2-3-fold dif ference) were retrospectively evaluated, no statistical difference was found in induction times, and no observable clinical differences in the anaesthetic episodes were seen. Based on this study, the recommended dose range in roan antelope for this combination is 10-13 microg/kg A3080, 5-6 microg/kg medetomidine and 0.3-0.6 mg/kg ketamine. The anaesthesia produced by this combination was rapidly and completely reversed by i.m. or i.v. injections of naltrexone at 30 times the A3080 dose (x = 0.60+/-0.25 mg/kg) and atipamezole at 3 times the medetomidine dose (x = 38+/-20 microg/kg). No residual effects from ketamine were noted following reversal of A3080 and medetomidine. No mortality was associated with this protocol.

Objective: To evaluate anesthetic and cardiorespiratory effects of an intramuscular injection of a tiletamine-zolazepam-medetomidine combination in cheetahs., Design: Prospective study., Animals: 17 adult captive cheetahs., Procedure: The anesthetic combination was administered intramuscularly via a dart. Induction quality, duration of lateral recumbency, duration of recovery, and quality of anesthetic reversal with atipamezole were assessed. Cardiorespiratory variables (arterial blood gas partial pressures, arterial blood pressure, heart and respiratory rates, end-tidal CO2, oxygen saturation, and rectal temperature) were measured during anesthesia., Results: Sedation and lateral recumbency developed within 1.9 +/- 1.0 (mean +/- SD) and 4.3 +/- 2.0 minutes of drug administration, respectively. Clinically acceptable cardiorespiratory and blood gas values were recorded for at least 87 minutes after drug administration in all but 1 cheetah. Hypoxemia and arrhythmias developed in 1 cheetah breathing room air but resolved after treatment with oxygen. Hypertension developed in all cheetahs. Significant differences in heart and respiratory rates, mean arterial blood pressure, arterial pH, partial pressure of oxygen, and hemoglobin saturation were found between cheetahs that did and did not receive oxygen supplementation. After administration of atipamezole, sternal recumbency and mobility returned within 6.9 +/- 5.8 and 47.5 +/- 102.2 minutes, respectively. Postreversal sedation, which lasted approximately 4 hours, developed in 4 cheetahs., Clinical Implications: Tiletamine-zolazepam-medetomidine delivered via a dart provided an alternative method for induction and maintenance of anesthesia in cheetahs. Atipamezole at the dose used was effective for reversal of this combination in the initial phase of anesthesia.